Tubo-ovarian actinomycosis was observed after chemotherapy for breast cancer in a patient with an intrauterine device. Does chemotherapy increase the risk? How can it be prevented?
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
A study of the risk factors for Ureaplasma urealyticum infection and the predictive role of immunoinflammation.
J Infect Dev Ctries
December 2024
Tangshan Central Hospital, Tangshan, Hebei, People's Republic of China.
Introduction: Despite increasing awareness on the prevention of Ureaplasma urealyticum (Uu) infection, the high-risk factors responsible for infection in female patients in China are yet to be determined.
Methodology: The study included 3043 Chinese women. Cervical secretion samples were collected for Uu identification.
The Migration of an Intrauterine Device in the Bladder of an Asymptomatic Woman: A Case Report.
J Reprod Infertil
January 2024
Department of Obstetrics and Gynecology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Background: The use of intrauterine devices (IUDs) for contraception has increased in many countries. However, their application has some serious complications such as uterine perforation and injury to adjacent organs. The translocated IUD into the bladder is a very rare occurrence.
View Article and Find Full Text PDFAdverse events associated with umbilical vascular catheters in neonatal intensive care: Development of a risk prediction model.
Aust Crit Care
January 2025
Allied Health & Human Performance, Rosemary Bryant AO Research Centre, University of South Australia, Adelaide, SA, Australia.
Background: Adverse events associated with umbilical vascular catheters occur frequently in the neonatal intensive care unit. International guidelines recommend limiting catheter dwell time to reduce the risk of adverse events, and this drives clinical decision-making regarding catheter removal, yet other risk factors may also influence the risk of adverse events.
Objectives: The aim of this study was to develop a clinically useful risk prediction model that could be utilised in the neonatal intensive care unit to identify infants at a greater risk of developing an adverse event associated with umbilical vascular catheters.
[Factors influencing pain during intrauterine device insertion].
Gynecol Obstet Fertil Senol
January 2025
Département de Gynécologie et Obstétrique, Hôpital Nord, Assistance Publique Hôpitaux de Marseille, Chemin des Bourrely, 13015 Marseille, France.
Objectives: Fear of pain during intrauterine device (IUD) insertion remains a barrier to its adoption. In the absence of consensus on an optimal pharmacological strategy, it is crucial to determine the factors influencing this pain to reassure and improve the patient experience.
Methods: It was a prospective study conducted in Provence-Alpes-Côte d'Azur between August 2023 and 2024, interviewing adult patients and healthcare professionals during consultations for IUD insertion.
Generalized Systemic Allergic Dermatitis Presumed Due to a Copper Intrauterine Device.
Dermatitis
January 2025
Department of Dermatology, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!